BioTime Inc (NYSE American:BTX)

2.39
Delayed Data
As of 1:33pm ET
 -0.07 / -2.85%
Today’s Change
2.10
Today|||52-Week Range
3.50
+11.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues5.2M7.0M5.9M3.5M
 
 
 
 
 
Cost of Goods Sold837.1K1.1M358.0K168.0K
 
 
 
 
 
Depreciation And Amortization8.4M6.3M4.8M3.3M
 
 
 
 
 
 
Operating ExpensesGross Income-4.0M-405.0K808.0K-6.0K
 
 
 
 
 
General Expenses46.7M65.4M59.8M40.7M
 
 
 
 
 
Research And Development30.2M37.3M32.5M21.7M
 
 
 
 
 
Total Operating Expenses55.9M72.8M64.9M44.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-50.7M-65.8M-59.0M-40.7M
 
 
 
 
 
Extraordinary Credit0.000.000.0017.7M
 
 
Extraordinary Charge0.000.000.00-2.8M
 
 
Pre-Tax Equity Earnings---35.0K29.7M0.00
 
 
 
Interest Expense On Debt91.0K465.0K747.0K692.0K
 
 
 
 
 
Other Expenses-383.6K3.5M48.6M3.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-51.2M-62.7M18.6M-23.3M
 
 
 
 
 
Income Taxes-7.4M-4.5M0.000.00
 
 
 
Minority Interest-7.4M-11.1M-15.0M-3.3M
 
 
 
 
 
Preferred Dividend-86.8K-415.0K0.000.00
 
 
 
Net Income-36.4M-47.0M33.6M-20.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS66.5M79.7M97.3M114.5M
 
 
 
 
 
Shares To Calculate EPS Diluted66.5M79.7M99.6M114.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.55-$0.59$0.34-$0.17
 
 
 
 
 
EPS Diluted-$0.55-$0.59$0.34-$0.17